INITIAL SCHEDULE 13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 5, 2008

Accession Number

0000728889-08-000259

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →